BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31669253)

  • 1. Bone mineral density at different sites and 5 years mortality in end-stage renal disease patients: A cohort study.
    Iseri K; Qureshi AR; Dai L; Ripsweden J; Heimbürger O; Barany P; Bergström I; Stenvinkel P; Brismar TB; Lindholm B
    Bone; 2020 Jan; 130():115075. PubMed ID: 31669253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sparing effect of peritoneal dialysis vs hemodialysis on BMD changes and its impact on mortality.
    Iseri K; Qureshi AR; Ripsweden J; Heimbürger O; Barany P; Bergström IB; Stenvinkel P; Brismar TB; Lindholm B
    J Bone Miner Metab; 2021 Mar; 39(2):260-269. PubMed ID: 32888063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations among Geriatric Nutrition Risk Index, bone mineral density, body composition and handgrip strength in patients receiving hemodialysis.
    Chen SC; Chung WS; Wu PY; Huang JC; Chiu YW; Chang JM; Chen HC
    Nutrition; 2019 Sep; 65():6-12. PubMed ID: 31029923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vertebral bone density associates with coronary artery calcification and is an independent predictor of poor outcome in end-stage renal disease patients.
    Chen Z; Qureshi AR; Ripsweden J; Wennberg L; Heimburger O; Lindholm B; Barany P; Haarhaus M; Brismar TB; Stenvinkel P
    Bone; 2016 Nov; 92():50-57. PubMed ID: 27519971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trabecular bone score may indicate chronic kidney disease-mineral and bone disorder (CKD-MBD) phenotypes in hemodialysis patients: a prospective observational study.
    Yun HJ; Ryoo SR; Kim JE; Choi YJ; Park I; Shin GT; Kim H; Jeong JC
    BMC Nephrol; 2020 Jul; 21(1):299. PubMed ID: 32711466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants and survival implications of low bone mineral density in end-stage renal disease patients.
    Park SH; Jia T; Qureshi AR; Bárány P; Heimbürger O; Larsson TE; Axelsson J; Stenvinkel P; Lindholm B
    J Nephrol; 2013; 26(3):485-94. PubMed ID: 22976520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone density, microarchitecture, and material strength in chronic kidney disease patients at the time of kidney transplantation.
    Pérez-Sáez MJ; Herrera S; Prieto-Alhambra D; Vilaplana L; Nogués X; Vera M; Redondo-Pachón D; Mir M; Güerri R; Crespo M; Díez-Pérez A; Pascual J
    Osteoporos Int; 2017 Sep; 28(9):2723-2727. PubMed ID: 28497224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone mineral density in Palestinian patients with end-stage renal disease and the related clinical and biochemical factors: Cross-sectional study.
    Nazzal Z; Khader S; Zawyani H; Abdallah M; Sawalmeh O; Hamdan Z
    PLoS One; 2020; 15(11):e0241201. PubMed ID: 33180791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Femoral Neck X-Ray Absorptiometry Parameters and Peripheral Quantitative Computer Tomography Tibial Cortical Density Predict Survival in Dialysis Patients.
    Yap N; Wong P; McGinn S; Nery ML; Doyle J; Wells L; Clifton-Bligh P; Clifton-Bligh RJ
    Nephron; 2017; 136(3):183-192. PubMed ID: 28319943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone mineral density in end-stage renal disease patients: association with wasting, cardiovascular disease and mortality.
    Matsubara K; Suliman ME; Qureshi AR; Axelsson J; Martola L; Heimbürger O; Barany P; Stenvinkel P; Lindholm B
    Blood Purif; 2008; 26(3):284-90. PubMed ID: 18421213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteosarcopenia in patients with non-dialysis dependent chronic kidney disease.
    Montenegro J; Klein MRST; Bregman R; Prado CM; Barreto Silva MI
    Clin Nutr; 2022 Jun; 41(6):1218-1227. PubMed ID: 35504164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in association of lower bone mineral density with higher coronary calcification in female and male end-stage renal disease patients.
    Chen Z; Qureshi AR; Brismar TB; Ripsweden J; Haarhaus M; Barany P; Heimburger O; Lindholm B; Stenvinkel P
    BMC Nephrol; 2019 Feb; 20(1):59. PubMed ID: 30777028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin autofluorescence, arterial stiffness and Framingham risk score as predictors of clinical outcome in chronic kidney disease patients: a cohort study.
    Mukai H; Svedberg O; Lindholm B; Dai L; Heimbürger O; Barany P; Anderstam B; Stenvinkel P; Qureshi AR
    Nephrol Dial Transplant; 2019 Mar; 34(3):442-448. PubMed ID: 29378035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative analysis of nutritional parameters as predictors of outcome in male and female ESRD patients.
    Stenvinkel P; Barany P; Chung SH; Lindholm B; Heimbürger O
    Nephrol Dial Transplant; 2002 Jul; 17(7):1266-74. PubMed ID: 12105251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone Quality Assessment as Measured by Trabecular Bone Score in Patients With End-Stage Renal Disease on Dialysis.
    Yavropoulou MP; Vaios V; Pikilidou M; Chryssogonidis I; Sachinidou M; Tournis S; Makris K; Kotsa K; Daniilidis M; Haritanti A; Liakopoulos V
    J Clin Densitom; 2017; 20(4):490-497. PubMed ID: 28039046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total and bone-specific alkaline phosphatase are associated with bone mineral density over time in end-stage renal disease patients starting dialysis.
    Bergman A; Qureshi AR; Haarhaus M; Lindholm B; Barany P; Heimburger O; Stenvinkel P; Anderstam B
    J Nephrol; 2017 Apr; 30(2):255-262. PubMed ID: 26994005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors and renal outcomes of low bone mineral density in patients with non-dialysis chronic kidney disease.
    Hyun YY; Lee KB; Han SH; Choi KH; Park HC; Oh YK; Park SK; Oh KH; Ahn C;
    Osteoporos Int; 2020 Dec; 31(12):2373-2382. PubMed ID: 32642852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial differences in bone mineral density and bone loss among end-stage renal disease patients.
    Stehman-Breen CO; Sherrard D; Walker A; Sadler R; Alem A; Lindberg J
    Am J Kidney Dis; 1999 May; 33(5):941-6. PubMed ID: 10213653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-year cortical and trabecular bone loss in CKD-5D: biochemical and clinical predictors.
    Malluche HH; Monier-Faugere MC; Blomquist G; Davenport DL
    Osteoporos Int; 2018 Jan; 29(1):125-134. PubMed ID: 28993865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The trabecular bone score is associated with bone mineral density, markers of bone turnover and prevalent fracture in patients with end stage kidney disease.
    Aleksova J; Kurniawan S; Elder GJ
    Osteoporos Int; 2018 Jun; 29(6):1447-1455. PubMed ID: 29556678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.